Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells

21 May 2020

Abstract excerpt

Colorectal cancer (CRC) is the third most common type of cancer and the second most common cause of cancer-related death in the world. N-Butylidenephthalide (BP), a natural compound, inhibits several cancers, such as hepatoma, brain tumor and colon cancer. However, due to the unstable structure, the activity of BP is quickly lost after dissolution in an aqueous solution. A polycationic liposomal polyethylenimine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Natural Compounds in Disease Treatment
Share to Neurological Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32455622
DOI: 10.3390/molecules25102394

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer CellsPMID 32455622Read ↗

Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancerSemantic proximity Read ↗

Ligand conjugated lipid-based nanocarriers for cancer theranosticsSemantic proximity Read ↗

Design, Synthesis, Characterization, and Evaluation of the Anti-HT-29 Colorectal Cell Line Activity of Novel 8-Oxyquinolinate-Platinum(II)-Loaded Nanostructured Lipid Carriers Targeted with RiboflavinSemantic proximity Read ↗

Dispiro-indanedione hybrid of parthenin induces p53-independent apoptosis and suppresses tumor progression in colorectal cancer modelsSemantic proximity Read ↗

In vitro anticancer activity of hydatid cyst fluid on colon cancer cell line (C26)Semantic proximity Read ↗

A super-assembled synergistically nanoplatform AP@ZIF-8 Pt for hepatocarcinoma therapySemantic proximity Read ↗

Adavosertib-encapsulated metal-organic frameworks for p53-mutated gallbladder cancer treatment via synthetic lethality.Semantic proximity Read ↗

p28-Mediated Activation of p53 in G2–M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic ChemotherapySemantic proximity Read ↗

Cancer cell membrane-coated PLGA nanoparticles deliver lupiwighteone to target EGFR and suppress hepatocellular carcinomaSemantic proximity Read ↗

Deregulation of miR-34a, miR-221 and miR-222 after HT29 cells treatment with Silibinin encapsulated in polymersomes as an anti-cancer stem cell agentSemantic proximity Read ↗

Innovations and Mechanisms in Liposomal Drug Delivery: A Comprehensive IntroductionSemantic proximity Read ↗

Molecular Insights into the Management of Eugenol's Anticancer Action Against Colon Cancer: A Detailed ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.